Ionis Pharmaceuticals IONS Ionis Operations — Research And Development Support Expenses

Similar metrics at other companies

IQVResearch & Development Solutions — Selling, general and administrative expenses

$250M+8.7%

IQVResearch And Development Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$971M+5.4%

IQVResearch & Development Solutions — Cost of revenues, exclusive of depreciation and amortization

$1.68B+8.0%

CGNXResearch, Development and Engineering Expenses — Other Expenses

$10.33M+4.0%

INCYReportable Segment — Research and development - internal

$260.18M+13.9%

INSMOther external R&D expenses — R&D

$32.68M+16.4%

Questions, answered.

What is Ionis Pharmaceuticals's ionis operations — research and development support expenses?

Ionis Pharmaceuticals (IONS) reported ionis operations — research and development support expenses of $22.43M in Q1 2026.

How has Ionis Pharmaceuticals's ionis operations — research and development support expenses changed year-over-year?

Ionis Pharmaceuticals's ionis operations — research and development support expenses increased by 9.1% year-over-year, from $20.55M to $22.43M.

What is the long-term trend for Ionis Pharmaceuticals's ionis operations — research and development support expenses?

Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — research and development support expenses has grown at a 16.6% compound annual growth rate (CAGR), from $59.84M to $94.85M.

What does ionis operations — research and development support expenses mean?

Indirect costs and overhead required to support the research and development organization.

How do you interpret ionis operations — research and development support expenses?

A steady or decreasing ratio relative to total R&D suggests operational efficiency in supporting research activities.

How does ionis operations — research and development support expenses compare across companies?

Comparable to R&D overhead or general research support costs at peer companies.